Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies. - Lin HY; Hu SC; Pai TY; Lin FJ; Wu CC (Drug design, development and therapy, 2025)